Dome JS - Search Results

1

Treatment and outcomes of clear cell sarcoma of the kidney: A report from the Children's Oncology Group studies AREN0321 and AREN03B2.

Benedetti DJ, Renfro LA, Tfirn I, Daw NC, Kalapurakal JA, Ehrlich PF, Khanna G, Perlman E, Warwick A, Gow KW, Paulino AC, Seibel NL, Grundy P, Fernandez CV, Geller JI, Mullen EA, Dome JS. Benedetti DJ, et al. Among authors: dome js. Cancer. 2024 Feb 23. doi: 10.1002/cncr.35266. Online ahead of print. Cancer. 2024. PMID: 38396300

2

High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor.

Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA, Grundy PE, Perlman EJ, Breslow NE, Sukumar S. Dome JS, et al. Cancer Res. 1999 Sep 1;59(17):4301-7. Cancer Res. 1999. PMID: 10485476

3

Treatment of refractory osteosarcoma with fractionated cyclophosphamide and etoposide.

Rodríguez-Galindo C, Daw NC, Kaste SC, Meyer WH, Dome JS, Pappo AS, Rao BN, Pratt CB. Rodríguez-Galindo C, et al. Among authors: dome js. J Pediatr Hematol Oncol. 2002 May;24(4):250-5. doi: 10.1097/00043426-200205000-00006. J Pediatr Hematol Oncol. 2002. PMID: 11972091

4

Improved survival for patients with recurrent Wilms tumor: the experience at St. Jude Children's Research Hospital.

Dome JS, Liu T, Krasin M, Lott L, Shearer P, Daw NC, Billups CA, Wilimas JA. Dome JS, et al. J Pediatr Hematol Oncol. 2002 Mar-Apr;24(3):192-8. doi: 10.1097/00043426-200203000-00007. J Pediatr Hematol Oncol. 2002. PMID: 11990305 Clinical Trial.

5

Management of Wilms' tumour: current practice and future goals.

Kalapurakal JA, Dome JS, Perlman EJ, Malogolowkin M, Haase GM, Grundy P, Coppes MJ. Kalapurakal JA, et al. Among authors: dome js. Lancet Oncol. 2004 Jan;5(1):37-46. doi: 10.1016/s1470-2045(03)01322-6. Lancet Oncol. 2004. PMID: 14700607 Review.

6

Telomerase expression predicts unfavorable outcome in osteosarcoma.

Sanders RP, Drissi R, Billups CA, Daw NC, Valentine MB, Dome JS. Sanders RP, et al. Among authors: dome js. J Clin Oncol. 2004 Sep 15;22(18):3790-7. doi: 10.1200/JCO.2004.03.043. J Clin Oncol. 2004. PMID: 15365076

7

Local lymph node involvement does not predict poor outcome in pediatric renal cell carcinoma.

Geller JI, Dome JS. Geller JI, et al. Among authors: dome js. Cancer. 2004 Oct 1;101(7):1575-83. doi: 10.1002/cncr.20548. Cancer. 2004. PMID: 15378495 Free article. Review.

8

High telomerase RNA expression level is an adverse prognostic factor for favorable-histology Wilms' tumor.

Dome JS, Bockhold CA, Li SM, Baker SD, Green DM, Perlman EJ, Hill DA, Breslow NE. Dome JS, et al. J Clin Oncol. 2005 Dec 20;23(36):9138-45. doi: 10.1200/JCO.2005.00.562. Epub 2005 Sep 19. J Clin Oncol. 2005. PMID: 16172460

9

Adjuvant therapy in pediatric patients with completely resected renal cell carcinoma.

Geller JI, Dome JS. Geller JI, et al. Among authors: dome js. Pediatr Blood Cancer. 2006 Apr;46(4):527. doi: 10.1002/pbc.20571. Pediatr Blood Cancer. 2006. PMID: 16365852 No abstract available.

10

Treatment of anaplastic histology Wilms' tumor: results from the fifth National Wilms' Tumor Study.

Dome JS, Cotton CA, Perlman EJ, Breslow NE, Kalapurakal JA, Ritchey ML, Grundy PE, Malogolowkin M, Beckwith JB, Shamberger RC, Haase GM, Coppes MJ, Coccia P, Kletzel M, Weetman RM, Donaldson M, Macklis RM, Green DM. Dome JS, et al. J Clin Oncol. 2006 May 20;24(15):2352-8. doi: 10.1200/JCO.2005.04.7852. J Clin Oncol. 2006. PMID: 16710034

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page